- Home
- ARBE vs AQST Comparison
ARBE vs AQST Comparison
Compare ARBE & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBE
- AQST
- Stock Information
- Founded
- ARBE 2015
- AQST 2004
- Country
- ARBE Israel
- AQST United States
- Employees
- ARBE N/A
- AQST N/A
- Industry
- ARBE EDP Services
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- ARBE Technology
- AQST Health Care
- Exchange
- ARBE Nasdaq
- AQST Nasdaq
- Market Cap
- ARBE 275.1M
- AQST 285.4M
- IPO Year
- ARBE N/A
- AQST 2018
- Fundamental
- Price
- ARBE $2.24
- AQST $3.01
- Analyst Decision
- ARBE Strong Buy
- AQST Strong Buy
- Analyst Count
- ARBE 2
- AQST 8
- Target Price
- ARBE $3.00
- AQST $10.38
- AVG Volume (30 Days)
- ARBE 7.6M
- AQST 2.0M
- Earning Date
- ARBE 03-05-2025
- AQST 03-05-2025
- Dividend Yield
- ARBE N/A
- AQST N/A
- EPS Growth
- ARBE N/A
- AQST N/A
- EPS
- ARBE N/A
- AQST N/A
- Revenue
- ARBE $1,016,000.00
- AQST $58,900,000.00
- Revenue This Year
- ARBE $1.56
- AQST $18.44
- Revenue Next Year
- ARBE $395.31
- AQST N/A
- P/E Ratio
- ARBE N/A
- AQST N/A
- Revenue Growth
- ARBE N/A
- AQST 22.56
- 52 Week Low
- ARBE $1.40
- AQST $2.24
- 52 Week High
- ARBE $5.09
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- ARBE 41.73
- AQST 43.29
- Support Level
- ARBE $2.62
- AQST $2.95
- Resistance Level
- ARBE $2.69
- AQST $3.21
- Average True Range (ATR)
- ARBE 0.25
- AQST 0.20
- MACD
- ARBE -0.06
- AQST 0.02
- Stochastic Oscillator
- ARBE 1.03
- AQST 18.42
About ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, USA, and others.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.